Oral Biologics & Biosimilar Drugs Global Market Report 2024

Global Oral Biologics & Biosimilar Drugs Market Report 2024

Oral Biologics & Biosimilar Drugs Global Market Report 2024 – By Therapy (Lymphocyte Modulators, Interleukin Inhibitors, Tumor Necrosis Factor-Alpha Inhibitors), By Disease (Asthma, Crohn's Disease, Carcinoma, Arthritis, Diabetes, Multiple Myeloma, Enterocolitis, Multiple Sclerosis, Sarcoma, Psoriasis and Others), By Molecule Type (Vaccines, Proteins & Peptides, Monoclonal Antibodies, Other Molecule Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033

Name: Oral Biologics & Biosimilar Drugs Global Market Report 2024
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Oral Biologics & Biosimilar Drugs Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 250 | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Oral Biologics & Biosimilar Drugs Global Market Report 2024

Proud Members Of

Oral Biologics & Biosimilar Drugs Market Definition

A biosimilar refers to a medication that closely resembles a biologic medication in both structure and function. A biologic drug, however, is a treatment created using a biological system, such as yeast, bacteria, or animal cells. A biological product is considered ""biosimilar"" if it is extremely similar to and bears no discernible clinical differences from an FDA-approved reference product already in use.

The main therapy types are oral biologics and biosimilar lymphocyte modulators, interleukin inhibitors, and tumor necrosis factor-alpha inhibitors. Interleukin inhibitors are immunosuppressive drugs that stop interleukins from working. Interleukins are a family of cytokines produced by lymphocytes, monocytes, macrophages, and a few other cells. They play an important role in immune system regulation. The various diseases treated include asthma, Crohn’s disease, carcinoma, arthritis, diabetes, multiple myeloma, enterocolitis, multiple sclerosis, sarcoma, psoriasis, and others, by vaccines, proteins and peptides, monoclonal antibodies, and others. The drugs are distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

Oral Biologics & Biosimilar Drugs Market Segmentation

The oral biologics & biosimilar drugs market covered in this report is segmented –

1) By Therapy: Lymphocyte Modulators, Interleukin Inhibitors, Tumor Necrosis Factor-Alpha Inhibitors

2) By Disease: Asthma, Crohn'S Disease, Carcinoma, Arthritis, Diabetes, Multiple Myeloma, Enterocolitis, Multiple Sclerosis, Sarcoma, Psoriasis and Others

3) By Molecule Type: Vaccines, Proteins & Peptides, Monoclonal Antibodies, Other Molecule Types

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Global Oral Biologics & Biosimilar Drugs Market Size 2023 to 2028: Graph

Oral Biologics & Biosimilar Drugs Market Size 2024 And Growth Rate

The oral biologics & biosimilar drugs market size has grown exponentially in recent years. It will grow from $5.94 billion in 2023 to $7.19 billion in 2024 at a compound annual growth rate (CAGR) of 21.0%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, growing awareness of oral biologics, increasing patent expirations, rising demand for biosimilars.

Oral Biologics & Biosimilar Drugs Market Growth Forecast

The oral biologics & biosimilar drugs market size is expected to see exponentially grown in the next few years. It will grow to $13.32 billion in 2028 at a compound annual growth rate (CAGR) of 16.7%. The growth in the forecast period can be attributed to targeted therapy, increasing focus on preventive medicine, rising healthcare spending, aging population. Major trends in the forecast period include advancements in oral delivery technology, orally administered biologics, biosimilar innovation, patient-centric care.

Book your 30 minutes free consultation with our research experts

Oral Biologics & Biosimilar Drugs Market Driver: Rising Prevalence Of Chronic Diseases Driving Growth In The Oral Biologics And Biosimilar Drugs Market

The rising prevalence of chronic diseases such as arthritis, asthma, and cancer is expected to be a major driver of the oral biologics and biosimilar market. Long working hours, limited physical activity, and unhealthy eating and drinking habits contribute to the prevalence of chronic diseases, and biologics are increasingly used to treat these chronic diseases. Biologics activate the immune system response against cancer cells thus helping the immune system to eliminate the cancer cells from the body. According to a United Nations article, by 2030 the proportion of global deaths due to chronic diseases is expected to increase to 70% of total deaths. The global burden of chronic disease is expected to reach about 60%. Therefore, the rise in the prevalence of chronic diseases is projected to propel the demand for biologics and biosimilars, thus driving the oral biologics & biosimilar drugs market growth.

Oral Biologics & Biosimilar Drugs Market Driver: Rising Demand For Personalized Medicine Driving Growth In The Oral Biologics And Biosimilars Market

The increasing demand for personalized medicine is expected to propel the growth of the oral biologics & biosimilar drugs market going forward. Personalized medicine refers to an innovative approach to medical treatment and healthcare that tailors medical decisions, practices, interventions, and drug therapies to the individual patient. There is a symbiotic relationship between the personalized medicine and the development and utilization of oral biologics and biosimilars, as personalized medicine approaches involve the use of biologics that focuses on optimizing treatment efficacy, minimizing side effects, reduces the trial-and-error approach including higher response rates and longer survival. For instance, in October 2022, according to reports published by STAT, a US-based health-oriented news company, there were more than 75,000 genetic testing products and 300 personalized medicines. Therefore, the increasing demand for personalized medicine is driving the growth of the oncology molecular diagnostics market.

Global Oral Biologics & Biosimilar Drugs Market Major Players

Major companies operating in the oral biologics & biosimilar drugs market include Novartis International AG, Rani Therapeutics Holdings Inc., Eli Lilly and Company, AstraZeneca plc, Novo Nordisk A/S, Biocon Limited, Oramed Pharmaceuticals Inc., BiosanaPharma, Entera Bio Ltd., Allergan plc, Emisphere Technologies Inc., Enteris BioPharma Inc., Chiasma Inc., Allena Pharmaceuticals Inc., Gelgen Corporation, Ganlee Corporation, 3SBio Inc., Innovent Biologics Inc., Retractable Technologies Inc., Changchun High & New Technology Industries (Group) Inc., Dong Bao Pharmaceutical Co. Ltd., CP Guojian Pharmaceutical Co. Ltd., GlaxoSmithKline PLC, Concord Biotech Limited, Aurobindo Pharma Limited, H. Lundbeck A/S, Sanofi S.A., F. Hoffmann-La Roche Ltd., Allergan Pharmaceuticals International Limited, Hikma Pharmaceuticals PLC, Mylan N.V., Pfizer Inc., Sandoz International GmbH, Teva Pharmaceutical Industries Ltd.

Global Oral Biologics & Biosimilar Drugs Market Restraint: Regulatory Hurdles And Regional Variations Impacting The Oral Biologics & Biosimilar Drugs Market

Stringent regulations imposed on the approval of biosimilar are anticipated to hinder the growth of oral biologics & biosimilar drugs market in the forecast period. The governments of different regions impose different rules regarding the production and use of biologics and biosimilars. Further, issues such as patent infringement or agreement issues restrict the manufacturers of biologics and biosimilars from commercializing the government-approved biosimilars. The US Food and Drug Administration requires double regulatory approval for biosimilars, restricting the use of biosimilars as an interchangeable drug for biologics whereas, in Europe, the European Medicines Agency (EMA) approves biosimilars as interchangeable products for biologics. For instance, according to 2021 Biosimilars Trend Report, the FDA approved 3 biosimilars. The COVID-19 epidemic and the ensuing closure most likely slowed the approval of biosimilars. The robust government policies for approval of these drugs impact the manufacturers in oral biologics and biosimilar markets.

Global Oral Biologics & Biosimilar Drugs Market Trend: The Emergence Of New Insulin Biosimilars In The Oral Biologics And Biosimilar Market

The latest trend in the oral biologics and biosimilar market is the creation of new insulin biosimilars. The key players operating in the oral biologics and biosimilar market are investing in creating a biosimilar copy of insulin. This is also promoting competition among various biosimilar manufacturers. For instance, in April 2023, Eli Lilly and Company, a US-based that manufactures oral biologics and biosimilar drugs launched insulin glargine biosimilar, Rezvoglar (insulin glargine-aglr). For type 1 diabetes in adults, children, and infants, as well as type 2 diabetes in adults, insulin glargine products are used to improve glycemic control.

Global Oral Biologics & Biosimilar Drugs Market Trend: Increasing Focus On Product Innovations To Provide Reliable Services To Their Customers

Major companies operating in the oral biologics and biosimilar markets market are focusing on innovative products such as interchangeable biosimilars to drive revenues in their market. Interchangeable biosimilars are a specific category of biosimilar drugs that meet additional regulatory requirements, typically in the United States, which allow them to be substituted for the reference biologic product without the intervention of the prescribing healthcare provider. For instance, in November 2021, Viatris Inc. a US-based company that manufactures biosimilar products and Biocon Biologics Limited, an India-based company that manufactures oral biologics and biosimilar drugs launched interchangeable biosimilars SEMGLEE (insulin glargine-yfgn) injection, and Insulin Glargine (insulin glargine-yfgn) injection. Both medications are used to help adults with type 2 diabetes and children’s patients with type 1 diabetes manage high blood sugar. Both biosimilar medications are interchangeable for the reference brand LANTUS (insulin glargine) and are offered in vial and prefilled pen formats, this enables substitution at the pharmacy counter.

Regional Outlook For The Global Oral Biologics & Biosimilar Drugs Market

North America was the largest region in the oral biologics and biosimilar drugs market in 2023. The Middle East is expected to be the fastest growing region in the oral biologics & biosimilar drugs market report during the forecast period. The regions covered in the oral biologics & biosimilar drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the oral biologics & biosimilar drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The oral biologics and biosimilar market consist of sales of therapeutic proteins, cystic fibrosis, somatic cells, and allergenics. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The oral biologics and biosimilar market research report is one of a series of new reports from The Business Research Company that provides oral biologics and biosimilar market statistics, including oral biologics and biosimilar industry global market size, regional shares, competitors with an oral biologics and biosimilar market share, detailed oral biologics and biosimilar market segments, market trends and opportunities, and any further data you may need to thrive in the oral biologics and biosimilar industry. This oral biologics and biosimilar market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Oral Biologics & Biosimilar Drugs Market Report Forecast And Analysis

Report Attribute	Details
Market Size Value In 2024	$7.19 billion
Revenue Forecast In 2033	$13.32 billion
Growth Rate	CAGR of 16.7% from 2024 to 2033
Base Year For Estimation	2023
Actual Estimates/Historical Data	2018-2023
Forecast Period	2024 - 2028 - 2033
Market Representation	Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered	1) By Therapy: Lymphocyte Modulators, Interleukin Inhibitors, Tumor Necrosis Factor-Alpha Inhibitors 2) By Disease: Asthma, Crohn's Disease, Carcinoma, Arthritis, Diabetes, Multiple Myeloma, Enterocolitis, Multiple Sclerosis, Sarcoma, Psoriasis and Others 3) By Molecule Type: Vaccines, Proteins & Peptides, Monoclonal Antibodies, Other Molecule Types 4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Regional Scope	Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Novartis International AG; Rani Therapeutics Holdings Inc.; Eli Lilly and Company; AstraZeneca plc; Novo Nordisk A/S; Biocon Limited; Oramed Pharmaceuticals Inc.; BiosanaPharma; Entera Bio Ltd.; Allergan plc; Emisphere Technologies Inc.; Enteris BioPharma Inc.; Chiasma Inc.; Allena Pharmaceuticals Inc.; Gelgen Corporation; Ganlee Corporation; 3SBio Inc.; Innovent Biologics Inc.; Retractable Technologies Inc.; Changchun High & New Technology Industries (Group) Inc.; Dong Bao Pharmaceutical Co. Ltd.; CP Guojian Pharmaceutical Co. Ltd.; GlaxoSmithKline PLC; Concord Biotech Limited; Aurobindo Pharma Limited; H. Lundbeck A/S; Sanofi S.A.; F. Hoffmann-La Roche Ltd.; Allergan Pharmaceuticals International Limited; Hikma Pharmaceuticals PLC; Mylan N.V.; Pfizer Inc.; Sandoz International GmbH; Teva Pharmaceutical Industries Ltd.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Oral Biologics & Biosimilar Drugs Market Characteristics

3. Oral Biologics & Biosimilar Drugs Market Trends And Strategies

4. Oral Biologics & Biosimilar Drugs Market - Macro Economic Scenario

4.1. Impact Of High Inflation On the Market

4.2. Ukraine-Russia War Impact On the Market

4.3. COVID-19 Impact On the Market

5. Global Oral Biologics & Biosimilar Drugs Market Size and Growth

5.1. Global Oral Biologics & Biosimilar Drugs Market Drivers and Restraints

5.1.1. Drivers Of The Market

5.1.2. Restraints Of The Market

5.2. Global Oral Biologics & Biosimilar Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

5.3. Global Oral Biologics & Biosimilar Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Oral Biologics & Biosimilar Drugs Market Segmentation

6.1. Global Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Lymphocyte Modulators

Interleukin Inhibitors

Tumor Necrosis Factor-Alpha Inhibitors

6.2. Global Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Asthma

Crohn's Disease

Carcinoma

Arthritis

Diabetes

Multiple Myeloma

Enterocolitis

Multiple Sclerosis

Sarcoma

Psoriasis and Others

6.3. Global Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Vaccines

Proteins & Peptides

Monoclonal Antibodies

Other Molecule Types

6.4. Global Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

7. Oral Biologics & Biosimilar Drugs Market Regional And Country Analysis

7.1. Global Oral Biologics & Biosimilar Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

7.2. Global Oral Biologics & Biosimilar Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Oral Biologics & Biosimilar Drugs Market

8.1. Asia-Pacific Oral Biologics & Biosimilar Drugs Market Overview

Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.3. Asia-Pacific Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.4. Asia-Pacific Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Oral Biologics & Biosimilar Drugs Market

9.1. China Oral Biologics & Biosimilar Drugs Market Overview

9.2. China Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.3. China Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.4. China Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Oral Biologics & Biosimilar Drugs Market

10.1. India Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.2. India Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.3. India Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Oral Biologics & Biosimilar Drugs Market

11.1. Japan Oral Biologics & Biosimilar Drugs Market Overview

11.2. Japan Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.3. Japan Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.4. Japan Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Oral Biologics & Biosimilar Drugs Market

12.1. Australia Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.2. Australia Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.3. Australia Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Oral Biologics & Biosimilar Drugs Market

13.1. Indonesia Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.2. Indonesia Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.3. Indonesia Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Oral Biologics & Biosimilar Drugs Market

14.1. South Korea Oral Biologics & Biosimilar Drugs Market Overview

14.2. South Korea Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.3. South Korea Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.4. South Korea Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Oral Biologics & Biosimilar Drugs Market

15.1. Western Europe Oral Biologics & Biosimilar Drugs Market Overview

15.2. Western Europe Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.3. Western Europe Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.4. Western Europe Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Oral Biologics & Biosimilar Drugs Market

16.1. UK Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.2. UK Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.3. UK Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Oral Biologics & Biosimilar Drugs Market

17.1. Germany Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.2. Germany Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.3. Germany Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Oral Biologics & Biosimilar Drugs Market

18.5. France Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.6. France Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.7. France Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Oral Biologics & Biosimilar Drugs Market

19.9. Italy Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.10. Italy Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.11. Italy Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Oral Biologics & Biosimilar Drugs Market

20.13. Spain Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.14. Spain Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.15. Spain Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Oral Biologics & Biosimilar Drugs Market

21.1. Eastern Europe Oral Biologics & Biosimilar Drugs Market Overview

21.2. Eastern Europe Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.3. Eastern Europe Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.4. Eastern Europe Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Oral Biologics & Biosimilar Drugs Market

22.1. Russia Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.2. Russia Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.3. Russia Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Oral Biologics & Biosimilar Drugs Market

23.1. North America Oral Biologics & Biosimilar Drugs Market Overview

23.2. North America Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.3. North America Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.4. North America Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Oral Biologics & Biosimilar Drugs Market

24.1. USA Oral Biologics & Biosimilar Drugs Market Overview

24.2. USA Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.3. USA Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.4. USA Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Oral Biologics & Biosimilar Drugs Market

25.1. Canada Oral Biologics & Biosimilar Drugs Market Overview

25.2. Canada Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.3. Canada Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.4. Canada Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Oral Biologics & Biosimilar Drugs Market

26.1. South America Oral Biologics & Biosimilar Drugs Market Overview

26.2. South America Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.3. South America Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.4. South America Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Oral Biologics & Biosimilar Drugs Market

27.1. Brazil Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.2. Brazil Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.3. Brazil Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Oral Biologics & Biosimilar Drugs Market

28.1. Middle East Oral Biologics & Biosimilar Drugs Market Overview

28.2. Middle East Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.3. Middle East Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.4. Middle East Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Oral Biologics & Biosimilar Drugs Market

29.1. Africa Oral Biologics & Biosimilar Drugs Market Overview

29.2. Africa Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.3. Africa Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.4. Africa Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Oral Biologics & Biosimilar Drugs Market Competitive Landscape And Company Profiles

30.1. Oral Biologics & Biosimilar Drugs Market Competitive Landscape

30.2. Oral Biologics & Biosimilar Drugs Market Company Profiles

30.2.1. Novartis International AG

30.2.1.1. Overview

30.2.1.2. Products and Services

30.2.1.3. Strategy

30.2.1.4. Financial Performance

30.2.2. Rani Therapeutics Holdings Inc.

30.2.2.1. Overview

30.2.2.2. Products and Services

30.2.2.3. Strategy

30.2.2.4. Financial Performance

30.2.3. Eli Lilly and Company

30.2.3.1. Overview

30.2.3.2. Products and Services

30.2.3.3. Strategy

30.2.3.4. Financial Performance

30.2.4. AstraZeneca plc

30.2.4.1. Overview

30.2.4.2. Products and Services

30.2.4.3. Strategy

30.2.4.4. Financial Performance

30.2.5. Novo Nordisk A/S

30.2.5.1. Overview

30.2.5.2. Products and Services

30.2.5.3. Strategy

30.2.5.4. Financial Performance

31. Global Oral Biologics & Biosimilar Drugs Market Competitive Benchmarking

32. Global Oral Biologics & Biosimilar Drugs Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Oral Biologics & Biosimilar Drugs Market

34. Oral Biologics & Biosimilar Drugs Market Future Outlook and Potential Analysis

34.1 Oral Biologics & Biosimilar Drugs Market In 2028 - Countries Offering Most New Opportunities

34.2 Oral Biologics & Biosimilar Drugs Market In 2028 - Segments Offering Most New Opportunities

34.3 Oral Biologics & Biosimilar Drugs Market In 2028 - Growth Strategies

34.3.1 Market Trend Based Strategies

34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations

35.2. Currencies

35.3. Historic And Forecast Inflation Rates

35.4. Research Inquiries

35.5. The Business Research Company

35.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 6: Global Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 7: Global Oral Biologics & Biosimilar Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 8: Global Oral Biologics & Biosimilar Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 9: Asia-Pacific, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 10: Asia-Pacific, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 11: Asia-Pacific, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 12: China, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 13: China, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 14: China, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 15: India, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 16: India, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 17: India, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 18: Japan, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 19: Japan, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 20: Japan, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 21: Australia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 22: Australia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 23: Australia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 24: Indonesia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 25: Indonesia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 26: Indonesia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 27: South Korea, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 28: South Korea, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 29: South Korea, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 30: Western Europe, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 31: Western Europe, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 32: Western Europe, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 33: UK, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 34: UK, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 35: UK, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 36: Germany, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 37: Germany, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 38: Germany, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 39: France, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 40: France, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 41: France, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 42: Italy, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 43: Italy, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 44: Italy, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 45: Spain, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 46: Spain, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 47: Spain, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 48: Eastern Europe, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 49: Eastern Europe, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 50: Eastern Europe, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 51: Russia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 52: Russia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 53: Russia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 54: North America, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 55: North America, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 56: North America, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 57: USA, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 58: USA, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 59: USA, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 60: Canada, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 61: Canada, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 62: Canada, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 63: South America, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 64: South America, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 65: South America, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 66: Brazil, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 67: Brazil, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 68: Brazil, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 69: Middle East, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 70: Middle East, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 71: Middle East, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 72: Africa, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 73: Africa, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 74: Africa, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 75: Novartis International AG Financial Performance

Table 76: Rani Therapeutics Holdings Inc. Financial Performance

Table 77: Eli Lilly and Company Financial Performance

Table 78: AstraZeneca plc Financial Performance

Table 79: Novo Nordisk A/S Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2018-2023, $ Billion

Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Figure 3: Global Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 4: Global Oral Biologics & Biosimilar Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 5: Global Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 6: Global Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 7: Global Oral Biologics & Biosimilar Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 8: Global Oral Biologics & Biosimilar Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 9: Asia-Pacific, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 10: Asia-Pacific, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 11: Asia-Pacific, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 12: China, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 13: China, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 14: China, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 15: India, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 16: India, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 17: India, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 18: Japan, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 19: Japan, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 20: Japan, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 21: Australia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 22: Australia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 23: Australia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 24: Indonesia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 25: Indonesia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 26: Indonesia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 27: South Korea, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 28: South Korea, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 29: South Korea, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 30: Western Europe, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 31: Western Europe, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 32: Western Europe, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 33: UK, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 34: UK, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 35: UK, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 36: Germany, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 37: Germany, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 38: Germany, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 39: France, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 40: France, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 41: France, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 42: Italy, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 43: Italy, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 44: Italy, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 45: Spain, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 46: Spain, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 47: Spain, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 48: Eastern Europe, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 49: Eastern Europe, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 50: Eastern Europe, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 51: Russia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 52: Russia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 53: Russia, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 54: North America, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 55: North America, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 56: North America, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 57: USA, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 58: USA, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 59: USA, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 60: Canada, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 61: Canada, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 62: Canada, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 63: South America, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 64: South America, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 65: South America, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 66: Brazil, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 67: Brazil, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 68: Brazil, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 69: Middle East, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 70: Middle East, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 71: Middle East, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 72: Africa, Oral Biologics & Biosimilar Drugs Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 73: Africa, Oral Biologics & Biosimilar Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 74: Africa, Oral Biologics & Biosimilar Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 75: Novartis International AG Financial Performance

Figure 76: Rani Therapeutics Holdings Inc. Financial Performance

Figure 77: Eli Lilly and Company Financial Performance

Figure 78: AstraZeneca plc Financial Performance

Figure 79: Novo Nordisk A/S Financial Performance

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Global Anticoagulants Market 2022 – Market Opportunities And Strategies

What Is The Compression Therapy Market Overview In 2022?

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the hiv drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the rituximab biosimilars market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the microbiome market research report 2022 with industry size, share, segments and market growth

Dental Practice Management Global Market Report 2024 – By Deployment Mode (Web based, Cloud based, On Premise), By Application (Patient Communication Software, Invoice/Billing Software, Payment Processing Software, Insurance Management, Other Applications), By End User (Dental Clinics, Hospitals, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Dental X-Ray Equipment Global Market Report 2024 – By Type (Extraoral X-Ray Systems, Intraoral X-Ray Systems, Hybrid X-Ray Systems), By Technology (Digital, Analog), By Application (Cosmetics, Medical, Forensics) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Dental Diagnostic Imaging Devices And Equipment Global Market Report 2024 – By Method (Intraoral Imaging, Extraoral Imaging), By Technology (X-Ray Systems, Dental Cone Beam Computed Tomography, Magnetic Resonance Imaging, Other Technologies), By End User (Hospitals, Dental Clinics, Forensic Labs, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Dental Equipment And Supplies Global Market Report 2024 – By Type (Therapeutic Dental Equipment, General Dental Devices And Equipment, Dental Diagnostic Imaging Devices And Equipment, Dental Surgical Devices And Equipment), By Type of Expenditure (Public, Private), By Product (Instruments/Equipment, Disposables), By End User (Hospitals And Clinics, Diagnostic Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Therapeutic Dental Equipment Global Market Report 2024 – By Product (Soft tissue Lasers, All tissue Lasers), By End user (Hospitals, Clinics, Dental laboratories), By Therapeutic Area (Restorative dentistry, Orthodontics, Endodontics, Other therapeutic areas) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Biologics Global Market Report 2024 – By Type (Monoclonal Antibodies (MAbS), Therapeutic Proteins, Vaccines), By Drug Classification (Branded Drugs, Generic Drugs), By Route Of Administration (Oral, Other Route Of Administration), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Biosimilars Global Market Report 2024 – By Type (Monoclonal Antibodies, Insulin, Erythropoietin, Granulocyte-Colony Stimulating Factor, Other Hormones, Others), By Product (Recombinant Non-glycosylated Proteins, Recombinant Glycosylated Proteins), By Application (Oncology, Chronic And Autoimmune Diseases, Growth Hormone Deficiency, Infectious Diseases, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Dental Services Global Market Report 2024 – By Type (General Dentistry, Oral Surgery, Orthodontics, Prosthodontics), By Type Of Procedure (Cosmetic Dentistry, Non-Cosmetic Dentistry), By Type Of Expenditure (Public, Private), By End-User (Gender) (Male, Female) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the oral biologics & biosimilar drugs market?

How will the oral biologics & biosimilar drugs market drivers and restraints affect the oral biologics & biosimilar drugs market dynamics? What forces will shape the oral biologics & biosimilar drugs industry going forward?

The oral biologics & biosimilar drugs market major growth driver - rising prevalence of chronic diseases driving growth in the oral biologics and biosimilar drugs market. For further insights on the oral biologics & biosimilar drugs market, request a sample here

What is the forecast market size or the forecast market value of the oral biologics & biosimilar drugs market?

The oral biologics & biosimilar drugs market size has grown exponentially in recent years. It will grow from $5.94 billion in 2023 to $7.19 billion in 2024 at a compound annual growth rate (CAGR) of 21.0%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, growing awareness of oral biologics, increasing patent expirations, rising demand for biosimilars. The oral biologics & biosimilar drugs market size is expected to see exponentially grown in the next few years. It will grow to $13.32 billion in 2028 at a compound annual growth rate (CAGR) of 16.7%. The growth in the forecast period can be attributed to targeted therapy, increasing focus on preventive medicine, rising healthcare spending, aging population. Major trends in the forecast period include advancements in oral delivery technology, orally administered biologics, biosimilar innovation, patient-centric care. For further insights on the oral biologics & biosimilar drugs market, request a sample here

How is the oral biologics & biosimilar drugs market segmented?

The oral biologics & biosimilar drugs market is segmented
1) By Therapy: Lymphocyte Modulators, Interleukin Inhibitors, Tumor Necrosis Factor-Alpha Inhibitors
2) By Disease: Asthma, Crohn'S Disease, Carcinoma, Arthritis, Diabetes, Multiple Myeloma, Enterocolitis, Multiple Sclerosis, Sarcoma, Psoriasis and Others
3) By Molecule Type: Vaccines, Proteins & Peptides, Monoclonal Antibodies, Other Molecule Types
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online PharmaciesFor further insights on the oral biologics & biosimilar drugs market, request a sample here

Which region has the largest share of the oral biologics & biosimilar drugs market? What are the other regions covered in the report?

North America was the largest region in the oral biologics and biosimilar drugs market in 2023. The Middle East is expected to be the fastest growing region in the oral biologics & biosimilar drugs market report during the forecast period. The regions covered in the oral biologics & biosimilar drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. For further insights on the oral biologics & biosimilar drugs market, request a sample here.

Who are the major players in the oral biologics & biosimilar drugs market?

What are the key trends in the oral biologics & biosimilar drugs market?

Major trend in the oral biologics & biosimilar drugs market - the emergence of new insulin biosimilars in the oral biologics and biosimilar market. For further insights on the oral biologics & biosimilar drugs market, request a sample here.

What are the major opportunities in the oral biologics & biosimilar drugs market? What are the strategies for the oral biologics & biosimilar drugs market?

For detailed insights on the major opportunities and strategies in the oral biologics & biosimilar drugs market, request a sample here.

How does the oral biologics & biosimilar drugs market relate to the overall economy and other similar markets?

For detailed insights on oral biologics & biosimilar drugs market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the oral biologics & biosimilar drugs industry?

For detailed insights on the mergers and acquisitions in the oral biologics & biosimilar drugs industry, request a sample here.

What are the key dynamics influencing the oral biologics & biosimilar drugs market growth? SWOT analysis of the oral biologics & biosimilar drugs market.

For detailed insights on the key dynamics influencing the oral biologics & biosimilar drugs market growth and SWOT analysis of the oral biologics & biosimilar drugs industry, request a sample here.